Covalx technology used on Patent Aplication.

Boston, MA: Covalx announces the use of Covalx technology in two important scientific projects: 1. “The United States Patent Application 20180237535: PD-L1 ANTIBODIES BINDING CANINE PD-L1. “Morsey, Mohamad (Omaha, NE, US), Zhang, Yuanzheng (Edison, NJ, US), Bartels-morozov, Denise (Fremont, NE, US), Erskine, Jason (Omaha, NE, US), Tarpey, Ian (St. Ives, GB)”. Publication Date: 08/23/2018,” Read more. and 2. “The Research Article: Extremely stable high molecular mass soluble multiprotein complex from eggs of sea urchin Strongylocentrotus intermedius with phosphatase activity. published on Wiley, Journal of Molecular Recognition, June 2018″.  Read more.

A recent patent application shows the use of Covalx technology for mapping of PD-L1 Epitopes: a method based on chemical cross-linking and mass spectroscopy detection to identify the epitopes recognized by anti-canine PD-L1

CovalX
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.